Fierce editors discuss a rough day for Valea...
Fierce editors discuss a fascinating Valeant...
Fierce editors discuss the latest turns in th...
Fierce editors discuss Sanofi's uninspiring f...
Fierce editors discuss the long-awaited merge...
In an episode free of Valeant Pharmaceuticals...
Fierce editors discuss the discussion around ...
Fierce editors discuss Shire's increasingly c...
Fierce editors discuss the future of Gilead S...
Fierce editors discuss a bizarre congression...